Trials / Recruiting
RecruitingNCT04328298
French Register Of Patients With Hemopathy Eligible For CAR-T Cell Treatment (DESCAR-T)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,000 (estimated)
- Sponsor
- The Lymphoma Academic Research Organisation · Academic / Other
- Sex
- All
- Age
- 0 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
This study is a registry including prospective and retrospective data on all patients who have been presented in a Multidisciplinary tumor board or RCP to be eligible for CAR-T cell treatment.
Conditions
Timeline
- Start date
- 2019-12-19
- Primary completion
- 2038-12-19
- Completion
- 2038-12-19
- First posted
- 2020-03-31
- Last updated
- 2026-03-04
Locations
36 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04328298. Inclusion in this directory is not an endorsement.